Bulltick Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Buy |
4,016
+3,341
| +495% | +$1.36M | 0.4% | 60 |
|
|
2025
Q1 | $336K | Sell |
675
-35
| -5% | -$17.4K | 0.09% | 102 |
|
|
2024
Q4 | $370K | Buy |
710
+2
| +0.3% | +$1.04K | 0.08% | 97 |
|
|
2024
Q3 | $438K | Buy |
708
+7
| +1% | +$4.33K | 0.11% | 86 |
|
|
2024
Q2 | $388K | Buy |
701
+36
| +5% | +$19.9K | 0.1% | 71 |
|
|
2024
Q1 | $387K | Buy |
665
+7
| +1% | +$4.07K | 0.07% | 84 |
|
|
2023
Q4 | $349K | Buy |
658
+2
| +0.3% | +$1.06K | 0.08% | 87 |
|
|
2023
Q3 | $332K | Buy |
656
+1
| +0.2% | +$507 | 0.08% | 94 |
|
|
2023
Q2 | $342K | Buy |
655
+3
| +0.5% | +$1.57K | 0.08% | 99 |
|
|
2023
Q1 | $376K | Sell |
652
-602
| -48% | -$347K | 0.1% | 92 |
|
|
2022
Q4 | $691K | Buy |
1,254
+91
| +8% | +$50.1K | 0.2% | 59 |
|
|
2022
Q3 | $590K | Buy |
1,163
+6
| +0.5% | +$3.05K | 0.18% | 66 |
|
|
2022
Q2 | $629K | Buy |
1,157
+107
| +10% | +$58.2K | 0.17% | 68 |
|
|
2022
Q1 | $620K | Sell |
1,050
-5
| -0.5% | -$2.96K | 0.14% | 72 |
|
|
2021
Q4 | $704K | Buy |
1,055
+593
| +128% | +$396K | 0.14% | 65 |
|
|
2021
Q3 | $264K | Hold |
462
| – | – | 0.06% | 108 |
|
|
2021
Q2 | $233K | Sell |
462
-1,065
| -70% | -$538K | 0.05% | 119 |
|
|
2021
Q1 | $697K | Buy |
+1,527
| New | +$697K | 0.19% | 47 |
|